CAR-T Cell Therapy for Desensitization in Kidney Transplantation

Conditions: Kidney Transplant; Kidney Failure; Highly Sensitized Interventions: Drug: Cyclophosphamide; Biological: CART-BCMA; Biological: huCART19; Drug: Fludarabine Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); University of Pennsylvania Clinical Cell and Vaccine Production Facility (CVPF) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials